Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Modified t-PA from Eisai highly effective thrombolytic

July 1, 1997

TIMI-IIA finds enoxaparin promising

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Thrombin inhibitors from Akzo Nobel

June 27, 1997

Orally active antithrombotic agents described by Pfizer

June 27, 1997

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

June 23, 1997

NicOx reveals antiinflammatory/antithrombotic compounds with low toxicity

June 20, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

June 17, 1997

Chimeric molecule shows promise as thrombolytic therapy

June 11, 1997

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...